VanEck Pharmaceutical ETF
PPH
#1025
ETF rank
A$1.79 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ US
Market
A$149.96
Share price
-0.24%
Change (1 day)
8.69%
Change (1 year)

Expense ratio and fees for VanEck Pharmaceutical ETF (PPH)

Expense Ratio

Expense Ratio as of May 2025: 0.36%

Gross Expense Ratio

Gross Expense Ratio as of December 2025: 0.36%

Net Expense Ratio

Net Expense Ratio as of December 2025: 0.36%